Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function in deceased donor kidney transplantatio

Phase 2

Recruiting

• Conditions: acute kidney damage; acute kidney injury; 10038430

• Registration Number: NL-OMON51462
• Lead Sponsor: efrologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

- Age > 18
- Recipients of a donor awaiting cardiac death on the intensive care
(definition of a donor cardiac death type III according to the *Maastricht
classification*)
- Written informed consent

Exclusion Criteria

- Strict vegetarians or vegans
- History of allergy to bovine proteins

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- Difference between treatment and placebo group in duration of<br /><br>delayed graft failure (DGF). DGF is defined as need for dialysis,<br /><br>excluding short sessions for hyperkalemia. DGF is defined as need for<br /><br>dialysis, excluding single sessions for hyperkalemia.</p><br>